comparemela.com

Zevra Therapeutics Presents Design of Phase 2 Clinical Trial Investigating KP1077 for the Treatment of Idiopathic Hypersomnia (IH) at Beyond Sleepy 2023

Zevra Therapeutics Presents Design of Phase 2 Clinical Trial Investigating KP1077 for the Treatment of Idiopathic Hypersomnia (IH) at Beyond Sleepy 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Nichol Ochsner ,Jennifer Arcure ,Christopher Drake ,Rene Braeckman ,Christal Mickle ,Exchange Commission ,European Medicines Agency ,Hypersomnia Foundation ,Drug Administration ,Corium Inc ,Clinical Development ,Henry Ford Health ,Company Early Access Program ,Us Drug Enforcement Agency ,Zevra Therapeutics Inc ,Wall Street ,Beyond Sleepy ,Sleepy Conference ,Beyond Sleep ,Chief Executive Officer ,Chief Development Officer ,Orphan Drug Designation ,Clinical Study ,Vice President ,Sleep Research ,Associated Professional Sleep Societies ,Enforcement Agency ,Fast Track ,Breakthrough Therapy ,New Drug Application ,Zevra Therapeutics ,Early Access Program ,Concerning Forward Looking Statements ,Private Securities Litigation Reform Act ,Investigational New Drug ,Annual Report ,Quarterly Report ,

comparemela.com © 2020. All Rights Reserved.